Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target

Junya Arai(The University of Tokyo), Mitsuhiro Fujishiro(Bunkyo University), Keisuke Yamamoto(Sapporo Medical University), Hiroto Kinoshita(The University of Tokyo), Tetsuo Ushiku(The University of Tokyo), Shinsuke Shibata(Keio University), Sozaburo Ihara(The University of Tokyo), Susan L. Woods(South Australian Health and Medical Research Institute), Sohei Abe(The University of Tokyo), Chifumi Fujii(Shinshu University), Nobumi Suzuki(The University of Tokyo), Masahiro Hata(University of Tokyo Hospital), Yuki Matsushita(University of Tokyo Hospital), Satoshi Kawamura(University of Tokyo Hospital), Yoshihiro Hirata(Tokyo Medical University), Masanori Hatakeyama(Hokkaido University), Takeru Hayashi(Microbial Chemistry Research Foundation), Chie Uekura(The University of Tokyo), Yoku Hayakawa(The University of Tokyo), Hayato Nakagawa(RIKEN Center for Integrative Medical Sciences), Hiroaki Fujiwara(The Institute of Medical Science, Asahi Life Foundation), Hiroaki Tateno(University of Tsukuba), Seiya Mizuno(National Institute of Animal Health), Takashi Kudo(University of Tsukuba), Satoru Takahashi(University of Tsukuba), Chihiro Shiomi(The University of Tokyo), Timothy C. Wang(Columbia University), Yusuke Iwata(The University of Tokyo), Ken Kurokawa(The University of Tokyo), Jun Nakayama(Shiga University of Medical Science), T. Shiokawa(The University of Tokyo), Mayo Tsuboi(University of Tokyo Hospital), K. Murakami(The University of Tokyo), Ryota Niikura(The University of Tokyo), Yukiko Oya(Saitama Cancer Center), Daniel L. Worthley(Brisbane Hand & Upper Limb Research Institute)
Gastroenterology
April 6, 2024
Cited by 28


Related Papers